Awasthi, Samir
Wagner, Tyler
Venkatakrishnan, A. J.
Puranik, Arjun
Hurchik, Matthew
Agarwal, Vineet http://orcid.org/0000-0001-6235-5577
Conrad, Ian
Kirkup, Christian
Arunachalam, Raman
O’Horo, John http://orcid.org/0000-0002-0880-4498
Kremers, Walter
Kashyap, Rahul
Morice, William II
Halamka, John
Williams, Amy W.
Faubion, William A. Jr.
Badley, Andrew D. http://orcid.org/0000-0001-7796-7680
Gores, Gregory J.
Soundararajan, Venky http://orcid.org/0000-0001-7434-9211
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI120698)
amfAR, The Foundation for AIDS Research (109593-62-RGRL)
Article History
Received: 27 September 2020
Revised: 14 November 2020
Accepted: 4 December 2020
First Online: 15 March 2021
Ethics statement
: IRB approval was obtained for this work as described above.
: ADB is supported by Grants AI110173 and AI120698 from NIAID, 109593-62-RGRL from Amfar, and the HH Sheikh Khalifa Bin Zayed Al-Nahyan named professorship from Mayo Clinic. ADB is a consultant for Abbvie, is on scientific advisory boards for Nference and Zentalis, and is founder and President of Splissen therapeutics. WK reports grants from AstraZeneca, grants from Biogen, grants from Roche, outside the submitted work. One or more of the investigators from the Mayo Clinic associated with this project and Mayo Clinic have a Financial Conflict of Interest in the technology used in the research and that the investigator(s) and Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies. The authors on this manuscript from nference have equity in nference and have a financial interest in nference.